LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | CP724714 | 0.37 | uM | LJP5 | 72 | hr | 1311 | 4803 | 5013 | 0.9581 | 0.9432 |
MDA-MB-231 | CP466722 | 0.37 | uM | LJP5 | 72 | hr | 1311 | 5060 | 5013 | 1.0093 | 1.0126 |
MDA-MB-231 | Crizotinib | 0.37 | uM | LJP5 | 72 | hr | 1311 | 4136 | 5013 | 0.8250 | 0.7630 |
MDA-MB-231 | Momelotinib | 0.37 | uM | LJP5 | 72 | hr | 1311 | 3767 | 5013 | 0.7514 | 0.6633 |
MDA-MB-231 | Dasatinib | 0.37 | uM | LJP5 | 72 | hr | 1311 | 927 | 5013 | 0.1849 | -0.1039 |
MDA-MB-231 | Dasatinib | 0.37 | uM | LJP6 | 72 | hr | 1311 | 916 | 5013 | 0.1828 | -0.1067 |
MDA-MB-231 | Dovitinib | 0.37 | uM | LJP5 | 72 | hr | 1311 | 3488 | 5013 | 0.6957 | 0.5879 |
MDA-MB-231 | Enzastaurin | 0.37 | uM | LJP5 | 72 | hr | 1311 | 4838 | 5013 | 0.9651 | 0.9527 |
MDA-MB-231 | Erlotinib | 0.37 | uM | LJP5 | 72 | hr | 1311 | 5018 | 5013 | 1.0010 | 1.0014 |
MDA-MB-231 | Foretinib | 0.37 | uM | LJP5 | 72 | hr | 1311 | 1692 | 5013 | 0.3376 | 0.1028 |
MDA-MB-231 | R406 | 0.37 | uM | LJP6 | 72 | hr | 1311 | 4396 | 5013 | 0.8769 | 0.8333 |
MDA-MB-231 | Pictilisib | 0.37 | uM | LJP6 | 72 | hr | 1311 | 3718 | 5013 | 0.7417 | 0.6501 |
MDA-MB-231 | Gefitinib | 0.37 | uM | LJP6 | 72 | hr | 1311 | 5011 | 5013 | 0.9996 | 0.9995 |
MDA-MB-231 | Geldanamycin | 0.37 | uM | LJP5 | 72 | hr | 1311 | 1282 | 5013 | 0.2557 | -0.0080 |
MDA-MB-231 | Geldanamycin | 0.37 | uM | LJP6 | 72 | hr | 1311 | 1247 | 5013 | 0.2487 | -0.0175 |
MDA-MB-231 | GSK1059615 | 0.37 | uM | LJP5 | 72 | hr | 1311 | 4830 | 5013 | 0.9635 | 0.9506 |
MDA-MB-231 | GSK1059615 | 0.37 | uM | LJP6 | 72 | hr | 1311 | 4887 | 5013 | 0.9749 | 0.9660 |
MDA-MB-231 | GSK1904529A | 0.37 | uM | LJP6 | 72 | hr | 1311 | 4427 | 5013 | 0.8831 | 0.8417 |
MDA-MB-231 | Omipalisib | 0.37 | uM | LJP6 | 72 | hr | 1311 | 1528 | 5013 | 0.3048 | 0.0584 |
MDA-MB-231 | GSK 690693 | 0.37 | uM | LJP5 | 72 | hr | 1311 | 4632 | 5013 | 0.9240 | 0.8971 |
MDA-MB-231 | GW843682X | 0.37 | uM | LJP6 | 72 | hr | 1311 | 3026 | 5013 | 0.6036 | 0.4631 |
MDA-MB-231 | HG-5-113-01 | 0.37 | uM | LJP5 | 72 | hr | 1311 | 4160 | 5013 | 0.8299 | 0.7696 |
MDA-MB-231 | HG-5-88-01 | 0.37 | uM | LJP6 | 72 | hr | 1311 | 4245 | 5013 | 0.8467 | 0.7924 |
MDA-MB-231 | Imatinib | 0.37 | uM | LJP6 | 72 | hr | 1311 | 4897 | 5013 | 0.9768 | 0.9686 |
MDA-MB-231 | JNK-9L | 0.37 | uM | LJP6 | 72 | hr | 1311 | 2934 | 5013 | 0.5852 | 0.4382 |